Risk for Mortality in High versus Low Antiparkinsonian Therapy Dose During the First Year of Parkinson's Disease: A Real-World Study. [PDF]
Barer Y+9 more
europepmc +1 more source
Test, track, treat using wearable sensors for management of Parkinson's disease: 12‑month prospective observational United Arab Emirates study using Parkinson's Kinetograph (EmPark-PKG Study). [PDF]
Metta V+7 more
europepmc +1 more source
Levodopa influence on turning dynamics in people with Parkinson's disease. [PDF]
Pillai L, Landes RD, Virmani T.
europepmc +1 more source
The akinetic crisis in Parkinson´s disease- the upper end of a spectrum of subacute akinetic states. [PDF]
Pötter-Nerger M+3 more
europepmc +1 more source
Risk factors for 3-year mortality in selected patients with Parkinson's disease from a Romanian cohort. [PDF]
Sipos-Lascu D+4 more
europepmc +1 more source
Sparse item testing of clinical scales in neurology trials to alleviate burden to patients. [PDF]
Chen C+4 more
europepmc +1 more source
Anticholinergic medication use and falls in postmenopausal women: findings from the women’s health initiative cohort study [PDF]
core +1 more source
Medication recommendation for Parkinson's disease based on dynamics of symptom progression. [PDF]
Oh M, Kim H, Lee HK.
europepmc +1 more source
Access to Medicines for Parkinson's Disease in Kenya: A Qualitative Exploration. [PDF]
Fothergill-Misbah N+3 more
europepmc +1 more source
Integrated approach of scalp electroacupuncture and pharmacotherapy in managing Parkinson's disease: A systematic review, meta-analysis, and trial sequential analysis of randomized clinical trials. [PDF]
Li H, Ju G, Chen J, Wang Y.
europepmc +1 more source